Healthcare provider profile · identity verified

Andrew Bradley Wolf, NP

Nurse Practitioner · BROOKLYN, NY · NPI 1144792110

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	199	91
Amlodipine Besylate	Amlodipine Besylate	185	84
Eliquis	Apixaban	185	59
Diclofenac Sodium	Diclofenac Sodium	181	66
Levothyroxine Sodium	Levothyroxine Sodium	166	82
Furosemide	Furosemide	152	61
Metoprolol Succinate	Metoprolol Succinate	126	60
Gabapentin	Gabapentin	124	49
Omeprazole	Omeprazole	110	37
Linzess	Linaclotide	102	29
Losartan Potassium	Losartan Potassium	99	38
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	97	48
Memantine Hcl	Memantine Hcl	96	32
Metformin Hcl	Metformin Hcl	94	37
Silver Sulfadiazine	Silver Sulfadiazine	93	43
Rosuvastatin Calcium	Rosuvastatin Calcium	88	42
Metoprolol Tartrate	Metoprolol Tartrate	87	34
Mirtazapine	Mirtazapine	87	26
Tamsulosin Hcl	Tamsulosin Hcl	87	40
Ammonium Lactate	Ammonium Lactate	83	38
Albuterol Sulfate Hfa	Albuterol Sulfate	80	34
Pantoprazole Sodium	Pantoprazole Sodium	80	40
Januvia	Sitagliptin Phosphate	79	22
Famotidine	Famotidine	77	30
Azithromycin	Azithromycin	74	47
Carvedilol	Carvedilol	65	33
Nystatin	Nystatin	62	24
Trazodone Hcl	Trazodone Hcl	62	29
Simvastatin	Simvastatin	55	20
Ibuprofen	Ibuprofen	54	38
Lisinopril	Lisinopril	54	24
Clopidogrel	Clopidogrel Bisulfate	53	26
Meclizine Hcl	Meclizine Hcl	53	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	51	42
Hydrochlorothiazide	Hydrochlorothiazide	51	14
Zenpep	Lipase/Protease/Amylase	50	13
Dexlansoprazole Dr	Dexlansoprazole	48	13
Allopurinol	Allopurinol	45	21
Hydralazine Hcl	Hydralazine Hcl	44	23
Hydrocortisone	Hydrocortisone	44	20
Escitalopram Oxalate	Escitalopram Oxalate	42	22
Sertraline Hcl	Sertraline Hcl	42	17
Donepezil Hcl	Donepezil Hcl	41	21
Entresto	Sacubitril/Valsartan	39	14
Janumet	Sitagliptin Phos/Metformin Hcl	39	suppressed
Myrbetriq	Mirabegron	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	36
Ketoconazole	Ketoconazole	37	11
Icosapent Ethyl	Icosapent Ethyl	35	16
Ozempic	Semaglutide	35	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	34	12
Creon	Lipase/Protease/Amylase	34	12
Duloxetine Hcl	Duloxetine Hcl	34	12
Finasteride	Finasteride	33	14
Nystop	Nystatin	33	suppressed
Meloxicam	Meloxicam	32	16
Montelukast Sodium	Montelukast Sodium	32	11
Quetiapine Fumarate	Quetiapine Fumarate	32	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	27
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Latanoprost	Latanoprost	28	13
Vascepa	Icosapent Ethyl	28	14
Fluticasone Propionate	Fluticasone Propionate	27	15
Clonidine Hcl	Clonidine Hcl	26	12
Ezetimibe	Ezetimibe	26	11
Enalapril Maleate	Enalapril Maleate	25	12
Mupirocin	Mupirocin	25	11
Jardiance	Empagliflozin	24	12
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Loperamide	Loperamide Hcl	23	16
Ofloxacin	Ofloxacin	23	16
Valsartan	Valsartan	23	11
Glipizide	Glipizide	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	14
Nifedipine Er	Nifedipine	20	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Restasis	Cyclosporine	20	suppressed
Levetiracetam	Levetiracetam	19	11
Potassium Chloride	Potassium Chloride	19	suppressed
Prednisone	Prednisone	19	12
Ssd	Silver Sulfadiazine	19	12
Labetalol Hcl	Labetalol Hcl	18	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	18	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Halobetasol Propionate	Halobetasol Propionate	16	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cyclosporine	Cyclosporine	14	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Lactulose	Lactulose	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Santyl	Collagenase Clostridium Hist.	12	suppressed
Topiramate	Topiramate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Atenolol	Atenolol	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error